Présentation
COVID-19 Vaccine Label: User Evaluation
In order to unify the labeling requirements for COVID-19 vaccines that will be supplied through the Access to COVID-19 Tools (Act) Accelerator, draft models for the vial labels and packaging have been proposed by the World Health Organization and Coalition for Epidemic Preparedness Innovation (CEPI). PATH's Living Labs Initiative used human-centered design methods to engage healthcare workers in Kenya and Zambia to evaluate these draft models. Their feedback on their desired features of vaccine labels and packaging have informed a series of recommendations for manufacturers for future vaccine vial development and for universal training guidelines for immunizations workers on the COVID-19 vaccine.
Auteurs
Langues
- Anglais
Année de publication
2021
Type
Présentation
Catégories
- Vaccins et dispositifs d'administration
Maladies
- COVID-19
Pays
- Kenya
- Zambie
Mots-clés
- Traçabilité
Régions de l'OMS
- Région africaine
PATH-LLI
Vous pouvez trouver plus d’informations sur "PATH-LLI" dans les rubriques suivantes :
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| Meet the health workers who will co-create solutions for vaccine delivery | PATH | 2019 | Case study | Anglais |
| To optimize COVID-19 vaccine rollout, listen to health workers | PATH | 2021 | Guidance | Anglais |
| Living Labs Initiative Overview | PATH, PATH Living Labs | 2021 | Guidance | Anglais |
| COVID-19 Vaccine Label: User Evaluation | PATH | 2021 | Presentation | Anglais |
